Logo image of FRE.DE

FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:FRE - DE0005785604 - Common Stock

49.75 EUR
+0.78 (+1.59%)
Last: 1/8/2026, 7:00:00 PM
Fundamental Rating

4

FRE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 29 industry peers in the Health Care Providers & Services industry. FRE has only an average score on both its financial health and profitability. FRE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year FRE was profitable.
FRE had a positive operating cash flow in the past year.
FRE had positive earnings in 4 of the past 5 years.
Each year in the past 5 years FRE had a positive operating cash flow.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

FRE has a Return On Assets (2.69%) which is comparable to the rest of the industry.
With a Return On Equity value of 6.14%, FRE perfoms like the industry average, outperforming 48.28% of the companies in the same industry.
FRE has a Return On Invested Capital of 3.26%. This is in the lower half of the industry: FRE underperforms 65.52% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FRE is below the industry average of 6.33%.
The last Return On Invested Capital (3.26%) for FRE is above the 3 year average (1.83%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROIC 3.26%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

FRE has a better Profit Margin (5.11%) than 89.66% of its industry peers.
FRE's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 9.76%, FRE belongs to the best of the industry, outperforming 86.21% of the companies in the same industry.
FRE's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 24.99%, FRE is in line with its industry, outperforming 55.17% of the companies in the same industry.
FRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

FRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
FRE has about the same amout of shares outstanding than it did 1 year ago.
FRE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for FRE has been reduced compared to a year ago.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

FRE has an Altman-Z score of 2.07. This is not the best score and indicates that FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of FRE (2.07) is comparable to the rest of the industry.
FRE has a debt to FCF ratio of 11.17. This is a negative value and a sign of low solvency as FRE would need 11.17 years to pay back of all of its debts.
The Debt to FCF ratio of FRE (11.17) is comparable to the rest of the industry.
FRE has a Debt/Equity ratio of 0.61. This is a neutral value indicating FRE is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.61, FRE belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Altman-Z 2.07
ROIC/WACC0.62
WACC5.29%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

FRE has a Current Ratio of 1.26. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.26, FRE is doing good in the industry, outperforming 68.97% of the companies in the same industry.
FRE has a Quick Ratio of 1.26. This is a bad value and indicates that FRE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of FRE (0.99) is better than 62.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.99
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 215.74% over the past year.
Measured over the past years, FRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.29% on average per year.
The Revenue has been growing slightly by 2.13% in the past year.
The Revenue has been decreasing by -9.22% on average over the past years.
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%

3.2 Future

Based on estimates for the next years, FRE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.63% on average per year.
The Revenue is expected to grow by 4.90% on average over the next years.
EPS Next Y15%
EPS Next 2Y12.68%
EPS Next 3Y11.74%
EPS Next 5Y10.63%
Revenue Next Year4.48%
Revenue Next 2Y4.84%
Revenue Next 3Y4.86%
Revenue Next 5Y4.9%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.59, FRE is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of FRE indicates a somewhat cheap valuation: FRE is cheaper than 75.86% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.00. FRE is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 13.02, FRE is valued correctly.
72.41% of the companies in the same industry are more expensive than FRE, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.70. FRE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.59
Fwd PE 13.02
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FRE is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FRE indicates a slightly more expensive valuation: FRE is more expensive than 68.97% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 23.37
EV/EBITDA 10.53
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.97
PEG (5Y)N/A
EPS Next 2Y12.68%
EPS Next 3Y11.74%

3

5. Dividend

5.1 Amount

FRE has a Yearly Dividend Yield of 2.04%. Purely for dividend investing, there may be better candidates out there.
FRE's Dividend Yield is a higher than the industry average which is at 1.45.
Compared to an average S&P500 Dividend Yield of 1.94, FRE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.04%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2016 2019 2020 2021 2022 2023 2025 0.5 1 1.5

5.3 Sustainability

59.84% of the earnings are spent on dividend by FRE. This is a bit on the high side, but may be sustainable.
DP59.84%
EPS Next 2Y12.68%
EPS Next 3Y11.74%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

FRESENIUS SE & CO KGAA

FRA:FRE (1/8/2026, 7:00:00 PM)

49.75

+0.78 (+1.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)03-25 2026-03-25/amc
Inst Owners46.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap28.02B
Revenue(TTM)22.35B
Net Income(TTM)1.14B
Analysts86.09
Price Target55.3 (11.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.04%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP59.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.22%
Min EPS beat(2)8.91%
Max EPS beat(2)13.53%
EPS beat(4)4
Avg EPS beat(4)13.17%
Min EPS beat(4)8.91%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)-25.39%
EPS beat(12)7
Avg EPS beat(12)-39.44%
EPS beat(16)8
Avg EPS beat(16)-31.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.68%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.27%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)0.88%
PT rev (3m)7.95%
EPS NQ rev (1m)0.39%
EPS NQ rev (3m)-11.25%
EPS NY rev (1m)1.6%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)0.1%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 14.59
Fwd PE 13.02
P/S 1.25
P/FCF 23.37
P/OCF 12.87
P/B 1.5
P/tB 15.13
EV/EBITDA 10.53
EPS(TTM)3.41
EY6.85%
EPS(NY)3.82
Fwd EY7.68%
FCF(TTM)2.13
FCFY4.28%
OCF(TTM)3.87
OCFY7.77%
SpS39.68
BVpS33.06
TBVpS3.29
PEG (NY)0.97
PEG (5Y)N/A
Graham Number50.37
Profitability
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROCE 6.63%
ROIC 3.26%
ROICexc 3.7%
ROICexgc 8.63%
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
FCFM 5.37%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexgc growth 3Y-17.75%
ROICexgc growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Debt/EBITDA 3.4
Cap/Depr 86.4%
Cap/Sales 4.38%
Interest Coverage 6.84
Cash Conversion 65.69%
Profit Quality 104.9%
Current Ratio 1.26
Quick Ratio 0.99
Altman-Z 2.07
F-Score7
WACC5.29%
ROIC/WACC0.62
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
EPS Next Y15%
EPS Next 2Y12.68%
EPS Next 3Y11.74%
EPS Next 5Y10.63%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
Revenue Next Year4.48%
Revenue Next 2Y4.84%
Revenue Next 3Y4.86%
Revenue Next 5Y4.9%
EBIT growth 1Y51.21%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year65.95%
EBIT Next 3Y24.42%
EBIT Next 5Y15.57%
FCF growth 1Y-61.64%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-52.6%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%

FRESENIUS SE & CO KGAA / FRE.DE FAQ

What is the fundamental rating for FRE stock?

ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE.


What is the valuation status for FRE stock?

ChartMill assigns a valuation rating of 4 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for FRESENIUS SE & CO KGAA?

FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.


What is the expected EPS growth for FRESENIUS SE & CO KGAA (FRE.DE) stock?

The Earnings per Share (EPS) of FRESENIUS SE & CO KGAA (FRE.DE) is expected to grow by 15% in the next year.


How sustainable is the dividend of FRESENIUS SE & CO KGAA (FRE.DE) stock?

The dividend rating of FRESENIUS SE & CO KGAA (FRE.DE) is 3 / 10 and the dividend payout ratio is 59.84%.